AB Science
Clinical trials sponsored by AB Science, explained in plain language.
AB Science
AB
EURONEXT PARIS
Develops small-molecule kinase inhibitors for cancer and inflammatory diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.